ISSOIRE, France – Chronicare, a company developing connected monitoring solutions for chronic disease patients, will integrate Biocorp’s Easlylog smart insulin pen cap device into its Chronicare Connect platform to improve medication adherence through remote monitoring, reminders and notifications, data analytics and coaching services. “As a smart sensor converting all insulin delivery devices into Internet-connected and communicating devices, Easylog is a keystone of Chronicare’s offering,” said Eric Dessertenne, deputy CEO of Biocorp, in a statement. “In addition, it enlarges the scope of partnerships that Biocorp has engaged through health systems, health care providers, disease management and population health companies. Incorporating Easylog into Chronicare Connect is strategic and our teams will continue to work hand in hand to make sure we’ll offer the best possible solution.” Easylog is a smart sensor that transforms all classic pen injectors, disposable and reusable, into smart, connected devices. It captures key treatment information like dose, date and time, and transfers it to the Chronicare Connect mobile app. This integrated solution includes other Bluetooth devices like a blood glucose meter and medication bottle cap, both of which connect to the Chronicare Connect platform to provide important patient treatment information. The company plans to add more connected devices to its portfolio as Chronicare expands into other chronic conditions.
You are here: / / Chronicare integrates Biocorp smart insulin pen cap into diabetes management platform